Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2003 Sep 27;327(7417):711.
doi: 10.1136/bmj.327.7417.711.

Drug points: Fatal lactic acidosis associated with tenofovir

Pablo Rivas  1 , Jorge Polo, Miguel de Górgolas, Manuel L Fernández-Guerrero
Affiliations
Case Reports

Drug points: Fatal lactic acidosis associated with tenofovir

Pablo Rivas et al. BMJ. .
No abstract available

PubMed Disclaimer

References

    1. FDA approves Viread for HIV-1 infection. FDA Consum 2002;36: 5. - PubMed
    1. Cheng A, Barriere S, Coackley DF, Chen SS, Wulfsohn M, Toole JJ. Safety profile of Tenofovir DF in antiretroviral treatment-experienced patients from randomized, double-blind, placebo-controlled clinical trials. 14th International AIDS Conference, Barcelona, July 2002. (Abstract No TuPeB4460.)
    1. Birkus G, Hitchcock MJ, Cihlar T. Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother 2002;46: 716-23. - PMC - PubMed
    1. Kakuda TN. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther 2000;22: 685-708. - PubMed
    1. Kearney BP, Damle B, Plummer A, Sayre J, Zhang X, Ryan K, et al. Tenofovir DF (TDF) and Didanosine EC (ddI EC): investigation of pharmacokinetic (PK) drug-drug and drug-food interactions. 14th International AIDS Conference, Barcelona, July 2002. (Abstract No LbPeB9026.)

Publication types